OC-0692: Phase 1 study of olaparib as radiosensitizer for locally advanced non-small cell lung cancer. (November 2020) - De Haan, R.; Van Diessen, J.; Peulen, H.M.U.; Van Werkhoven, E.; De Langen, A.J.; Lalezari, F.; Vens, C.; Schellens, J.; Steeghs, N.; Van Den Heuvel, M.M.; Verheij, M.; Van Triest, B.